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compared with ischemic heart disease − a
longitudinal study
Ghassan Mourad1*, Jenny Alwin2†, Anna Strömberg3† and Tiny Jaarsma1†Abstract
Background: Non-cardiac chest pain (NCCP) is a common complaint. Our aim was to present a detailed description of
the costs of patients with NCCP compared to patients with acute myocardial infarction (AMI) and Angina Pectoris (AP)
from a societal perspective.
Methods: Data on healthcare utilization and annual societal costs, including direct healthcare costs and indirect costs due
to productivity loss, were collected from different databases. The participants consisted of 199 patients from a general
hospital in Sweden (99 with NCCP, 51 with AMI, 49 with AP), mean age of 67 years, 59% men.
Results: NCCP, AMI, and AP patients had on average 54, 50 and 65 primary care contacts and 3, 4, and 4 hospital
admissions during a period of 2 years. Length of hospital stay was 6, 11 and 11 days. On average, 14%, 18%, and 25% of
NCCP, AMI and AP patients were on sick-leave annually, and about 12% in each group received a disability pension. The
mean annual societal costs of NCCP, AMI and AP patients were €10,068, €15,989 and €14,737.
Conclusions: Although the annual societal cost of NCCP patients was lower than in AMI and AP patients, the cost was
still considerable (€10,068). Taken into account the high prevalence of NCCP, the cumulative annual national cost of these
patients could be more than the double of AMI and AP if all patients incurred the same costs as in this study. Targeted
interventions are important in order to support patients with NCCP and minimize healthcare utilization and costs.
Keywords: Non-cardiac chest pain, Ischemic heart disease, Healthcare utilization, Societal costs, Direct costs, Indirect costsBackground
Non-cardiac chest pain (NCCP) can be defined as
angina-like pain that has not been diagnosed as ischemic
heart disease [1]. It can be caused by gastrointestinal dis-
eases, pulmonary disorders, chest wall syndromes, and
pleural and pericardial conditions. NCCP is often also
associated with psychiatric disorders and has been found
to decrease quality of life [2-4].
Patients suffering from NCCP are often younger, fe-
male, immigrants, and have a lower educational level
compared to patients suffering from ischemic heart dis-
ease [1,5,6]. The prevalence rate of NCCP is estimated
to be more than 50% of all chest pain cases presenting at* Correspondence: ghassan.mourad@liu.se
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reproduction in any medium, provided the orthe emergency department [3,7,8], which in turn is be-
tween 2% and 5% of all cases [9].
Patients with NCCP often seek care due to recurrent
and persistent chest pain [10-15]. Other reasons for
seeking care reported by patients are symptom anxiety,
anxiety due to the possibility of a serious disease and
symptom severity [1]. Patients suffering from NCCP have
been found to utilize out-patient healthcare to the same
extent as patients with acute myocardial infarction (AMI)
[2,4,15]. The majority of the patients seeking care due to
chest pain are admitted for in-hospital cardiac “rule out”
observation, but only one third of all cases are found to be
ischemic heart disease [12,16]. In many cases, patients re-
main undiagnosed despite investigation [17], even though
they could suffer from depressive symptoms [15].
A minority of NCCP patients are high users of healthcare
[2,5,7,15] and contribute to high costs for the healthcare
system [9,16,18]. According to Glombiewski et al. [12],l Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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fined as 2 or more visits to a cardiologist, or 3 or more car-
diac diagnostic investigations within a period of 6 months.
Yet, there is no research on the societal costs related to pa-
tients with NCCP, including costs of the patients’ healthcare
utilization and productivity loss. By calculating the societal
costs of NCCP, valuable information is obtained that can
play a central role in deciding the urgency to develop new
treatments for these patients in order to optimize the pa-
tient benefits from the money spent. The aim of the present
study was to present a detailed description of the costs of
patients with NCCP compared to patients with AMI and
Angina Pectoris (AP) from a societal perspective.
Research questions
(1)How much of healthcare resources do patients with
NCCP, AMI and AP utilize? What are the
differences between the index admission year and
the following year?
(2)What are the direct and indirect costs of patients with
NCCP, AMI and AP? What are the differences between
the index admission year and the following year?
(3)What are the annual societal costs for patients with
NCCP, AMI and AP?
(4)Which are the most cost driving units within
primary and hospital care in connection with
patients with NCCP, AMI and AP?
Methods
A longitudinal descriptive study of the costs of patients with
NCCP, AMI, and AP over a 2-year period was performed.Included (n=199)
Non-cardiac chest pain (n=99)
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Figure 1 Flow diagram illustrating patient enrolment.A societal perspective, including all costs of the patients’
healthcare utilization and productivity loss, was applied in
the analysis.
Enrolment
Two hundred and sixty seven patients who had been ad-
mitted to a medical unit, mainly the coronary care unit at
a general hospital, due to acute chest pain between July
and December 2008 and discharged with ICD- diagnoses
(International Classification of Diseases) of NCCP (ICD
10-code R07.4, chest pain unspecified; and ICD 10-code
Z03.4, observation for suspected myocardial infarction),
AMI (ICD 10-code I21) and AP (ICD 10-code I20), were
approached (Figure 1). The cohort was prevalence-based,
meaning that all patients diagnosed with NCCP, AMI or
AP during the study period were approached [19]. These
patients had participated in a previous study regarding de-
pressive symptom prevalence and healthcare utilization
[15]. At the 1-year follow-up, 260 surviving patients of the
267 who had been approached were invited to participate
in the present study. All participants were residents of
the County of Östergötland, which is the fourth largest
county in Sweden with 429,642 residents. About 19%
of Östergötland residents are older than 65, mean age
41 years, and the employment rate is 74% [20].
Data collection
Cost estimates
When estimating cost-of-illness, the cost-generating com-
ponents are identified and attributed a monetary value.
When assessing the total economic costs of illness, these
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care expenditures and the productivity costs measure pro-
duction lost due to morbidity and mortality [19,21].
All costs are reported in Euros (€) (€1 equals 8.6 Swedish
kronor as per January 3, 2013).Direct costs
The direct healthcare costs of patients with NCCP, AMI
and AP were defined as all costs related to diagnosis pro-
cedures and/or treatment within primary care, out-patient
clinics, and hospital care. All healthcare utilization of the
patients in the present study was included in the analyses,
regardless of the reason for the healthcare contact. The
costs are presented as hospital care including nursing/car-
ing staff and premises costs (hospital care), non-nursing
staff and treatment (hospital care), staff and treatment (pri-
mary and out-patient care), medical service, drugs, mate-
rials and medical devices, administrative contacts, and
various overhead costs (hospital, primary and out-patient
care). Medical service includes anaesthesia, surgery, post-
operative care, intensive care, radiology, and laboratory
services.
Data on the direct costs were collected from the Cost
Per Patient (CPP) database. This regional database,
which is run by Östergötland County Council, was intro-
duced by the Swedish Association of Local Authorities
and Regions, and provides patient-related cost informa-
tion about almost all healthcare within the county of
Östergötland [22].
The costs provided by the CPP database are based on
information from a regional care database called “Care
Data Warehouse”. This is a population-based diagnosis-
related administrative database run by Östergötland County
Council. The medical diagnoses are recorded according to
ICD-10. The Care Data Warehouse database contains
information about every healthcare visit/stay within the
county of Östergötland, except for some private practices
[23,24].Indirect costs
The indirect costs were mainly based on productivity loss
due to sick-leave, and also productivity loss due to disabil-
ity pension in cases of prolonged reduced work capacity.
The Human Capital approach, which is the most used
method [25], was used when estimating the indirect costs.
This means that the estimates were based on gross earn-
ings including employment overheads and benefits of the
individuals in employment, and in some cases also of
those not in paid employment, e.g. individuals who were
unemployed or on parental leave. By using this method,
adjustments were made for the opportunity cost of the
production the individuals could have contributed with if
they had been at work [19,21,26].Data on the indirect costs were collected from the
Social Insurance Agency database. All persons receiving
sickness benefit, regardless of employment status, were
included in the analysis. It was assumed that these indi-
viduals would be back in production. Data regarding
sick-leave are registered and paid by the Social Insurance
Agency to employed individuals on sick-leave from the
15th day of absence, and from the second day of sick-
leave to those who are unemployed or on parental leave.
We added the unregistered days to our calculations and the
total cost for sick-leave from day 1 is presented in those
with a sick-leave period longer than 14 days. Disability pen-
sion was paid to people between 30 and 64 years with at
least 25% reduced work capacity for at least 1 year [27].
The calculations of productivity loss were based on the
patients’ income. These data were obtained from a ques-
tionnaire completed by the patients. In the questionnaire,
the patients stated their income by marking 1 of 4 pre-
defined income ranges (Table 1). The mean value of the
income ranges “low, middle-range and high” (€1686,
€2500, and €4279) was used in the calculations. For the in-
come range “very low”, the maximum income of €1337
was used in the calculations. An employer’s tax of 50% was
added to the income.
Costs related to an individual due to pain and suffer-
ing or to family members for caring for the individual
or home care services were not included due to lack
of data.
Procedure
A letter including information about the study, written
informed consent and a pre-stamped envelope was sent
to all patients (n = 260). They were asked to permit that
data were collected from the different databases. After 3
and 6 weeks, a reminder was sent to those who had not
responded to the first mail-out. Patients declining partici-
pation were not contacted further. Two-year data were
collected from the different databases based on the per-
sonal identification numbers of the patients who agreed to
participate. Data were provided to the researchers on an
individual basis and for each contact with healthcare. The
data were calculated group-wise and year-wise by the re-
searchers. The 2-year period comprised 1 year including
index admission (i.e. admission when patients were
recruited) and the year following index admission.
Statistical analysis
IBM SPSS Statistics 20 was used to perform the statis-
tical analysis. Number, percent, mean and standard devi-
ation (SD) were used to describe the socio-demographic
variables. Between-group differences regarding socio-
demographic variables were calculated using analysis of
variance with the Bonferroni post hoc correction for con-
tinuous variables and χ2 test for categorical variables. Since
Table 1 Socio-demographic data of the patients with non-cardiac chest pain, acute myocardial infarction and
angina pectoris
Socio-demographic data
All patients Non-cardiac chest pain Acute myocardial infarction Angina Pectoris P-value
(N = 199) (n = 99) (n = 51) (n = 49)
Age year (m ± SD) 67 ± 13 64 ± 14 69 ± 12 69 ± 12 .01
Male sex n (%) 117 (59) 48 (49) 35 (69) 34 (69) .01
Married/cohabiting n (%) 144 (72) 72 (73) 40 (78) 32 (65) .34
Educational level n (%) .76
Compulsory school 82 (41) 43 (43) 17 (33) 22 (45)
High school 78 (39) 38 (39) 22 (43) 18 (37)
University 39 (20) 18 (18) 12 (24) 9 (18)
Work status n (%) .14
Workers 55 (28) 28 (28) 10 (20) 16 (33)
Retired 120 (60) 55 (56) 34 (66) 31 (63)
Sick-leave/disability pension 14 (7) 7 (7) 6 (12) 2 (4)
Unemployed 8 (4) 7 (7) 1 (2) 0 (0)
Students 2 (1) 2 (2) 0 (0) 0 (0)
Income n (%) .92
Very low (≤ €1337) 70 (35) 38 (38) 20 (39) 12 (25)
Low (€1337-2035) 62 (31) 27 (27) 14 (28) 21 (43)
Middle-range (€ 2035–2965) 44 (22) 24 (24) 10 (19) 10 (20)
High (≥ €2965) 23 (12) 10 (10) 7 (14) 6 (12)
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treatment needs between the 3 groups, no statistical differ-
ences between groups were calculated regarding health-
care utilization and costs, but comparisons were made on
a descriptive level in order to highlight and discuss similar-
ities and differences.
Mean values and standard deviations were used to de-
scribe healthcare utilization, such as number of primary
care and out-patient contacts, hospital admissions and
length of hospital stay, as well as direct and indirect
costs. Wilcoxon signed rank test was used to analyze dif-
ferences within groups regarding healthcare utilization
and costs over the 2 years. A rough estimate of the index
admission costs was made by dividing the total hospital
cost for the first year with the number of admissions. A
difference of p < .05 was considered significant.Ethical considerations
The study was approved by the Regional Ethical Review
Board in Linköping, Sweden (code M12-08 and M12-08
T118-09), and was carried out in accordance with the
Declaration of Helsinki. Study participation was based
on written informed consent, which was obtained from
all participants.Results
Study participants
Out of the 260 patients who were approached, a total of
199 (77%; 99 with NCCP, 51 with AMI and 49 with AP)
agreed to participate in the present study (Figure 1). The
participants ranged in age from 21 to 90 years with a mean
age of 67 years. Participants were mainly men (59%), mar-
ried (72%), retired (61%) and had a low income (66%)
(Table 1). Patients with NCCP were significantly younger
and did not differ regarding sex compared with the other 2
groups (p < .05). No other differences were found regarding
the socio-demographic variables. Non-participants (23%;
29 with NCCP, 14 with AMI and 18 with AP) did not differ
from the participants regarding sex, but patients with
NCCP were significantly younger (p = .05), and those with
AP were significantly older (p = .02).Healthcare utilization in patients with NCCP, AMI and AP
During the index admission year, patients with NCCP,
AMI, and AP had a mean of about 24, 16 and 27 pri-
mary care and out-patient contacts per patient (Table 2).
The mean number of primary care and out-patient con-
tacts were about 30, 34 and 38 per patient respectively,
during the following year, which was significantly higher
Table 2 Healthcare utilization in patients with non-cardiac chest pain, acute myocardial infarction and angina pectoris
Non-cardiac chest
pain (n = 99)
Acute myocardial
infarction (n = 51)
Angina
Pectoris (n = 49)
Year 1 Year 2 Year 1 Year 2 Year 1 Year 2
Mean number of primary care and out-patient
contacts per patient (m ± SD)
23.6 ± 27.0 30.0 ± 36.8 16.2 ± 13.4 33.6 ± 23.3 26.5 ± 23.0 38.3 ± 36.1
Mean number of hospital admissions per patient (m± SD) 1.7 ± 1.4 0.9 ± 1.8 3.0 ± 1.6 0.6 ± 0.9 2.6 ± 1.7 1.3 ± 1.8
Mean length of hospital stay, days per patient (m ± SD) 3.4 ± 5.2 2.9 ± 9.4 9.0 ± 8.8 1.9 ± 3.8 6.8 ± 6.1 3.7 ± 8.3
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for these contacts varied and were not only related to
the NCCP, AMI and AP diagnoses.
The first year, patients with NCCP had almost half the
number of hospital admissions per patient compared to
patients with AMI and AP, who had about 3 admissions
per patient. All 3 groups had significantly fewer admis-
sions (P < .001) during the second year compared to the
first (Table 2), and also significantly shorter hospital
stays the second year compared to the first (p < .01). The
causes for the admissions were directly related to the
NCCP, AMI and AP diagnoses in 80-85% of the admis-
sions in all groups.
Direct and indirect costs of patients with NCCP, AMI and AP
All costs within primary care, out-patient clinics and hos-




The annual costs for out-patient care at primary care
and out-patient clinics were higher the second year com-
pared to the first for patients with NCCP (p < .05) and
AMI (p < .01). The mean total cost per patient the firstTable 3 Annual direct cost per patient of non-cardiac chest p
Cost pe




Hospital care including nursing/caring
staff and premises costs*
0
Staff and treatment□ 1356
Medical service‡ 477
Drugs, materials and medical devices 955
Administrative contacts† 104
Overhead costs and other 321
Total cost 3212
* = Not relevant for primary care and out-patient clinics.
□ = In hospital care, the costs for nursing/caring staff are not included.
‡ =Medical service includes anaesthesia, surgery, postoperative care, intensive care
† = Administrative contacts mainly within primary care and out-patient clinics.year was €3212 for patients with NCCP, €2024 for patients
with AMI and €3089 for patients with AP (Table 6). The
corresponding costs for the second year were €3616,
€3112, and €3348 for patients with NCCP, AMI and AP
respectively.
Hospital care
During the first year, the mean hospital costs were €3803,
€16,387, and €10,785 per patient for patients with NCCP,
AMI and AP respectively. The corresponding costs for the
second year were €2962, €3103, and €4084. The annual
costs for hospital care were lower during the second
year compared to the first in patients with AMI and AP
(p < .01), but did not differ in patients with NCCP. A
rough estimate of the costs of the index admission resulted
in sums of €2237, €5462, and €4148 per patient for pa-
tients with NCCP, AMI and AP respectively.
Indirect costs
Sick-leave
In total, 21% of the study participants were on sick-leave
during the first year and 16% during the second year. In
terms of the diagnosis groups, patients with NCCP were
on sick-leave 16% and 11% the first and second year re-
spectively (Table 7). The corresponding numbers forain in Euros (€)
r patient of non-cardiac chest pain (n = 99)











Year 2 Year 1 Year 2 Year 1 Year 2
0 1203 1117 1203 1117
1530 572 418 1928 1948
591 1280 850 1757 1441
1002 408 308 1363 1310
141 2 8 106 149
351 339 262 660 613
3616 3803 2963 7016 6578
, radiology, and laboratory services.
Table 4 Annual direct cost per patient of acute myocardial infarction in Euros (€)
Cost per patient of acute myocardial infarction (n = 51)













Year 1 Year 2 Year 1 Year 2 Year 1 Year 2
Hospital care including nursing/caring
staff and premises costs*
0 0 3685 671 3685 671
Staff and treatment□ 865 1324 2237 343 3101 1667
Medical service‡ 287 483 8131 1610 8418 2092
Drugs, materials and medical devices 603 912 780 157 1383 1069
Administrative contacts† 66 82 6 0 72 82
Overhead costs and other 203 311 1548 322 1751 634
Total cost 2024 3112 16,387 3103 18,411 6215
* = Not relevant for primary care and out-patient clinics.
□ = In hospital care, the costs for nursing/caring staff are not included.
‡ =Medical service includes anaesthesia, surgery, postoperative care, intensive care, radiology, and laboratory services.
† = Administrative contacts mainly within primary care and out-patient clinics.
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with AP 27% and 22%. On average, patients with NCCP,
AMI and AP were on sick-leave 103, 54 and 94 days per
year respectively. Although fewer patients were on sick-
leave the second year compared to the first, these pa-
tients had longer periods of absence. In patients with
NCCP, the mean cost per patient due to productivity
loss because of sick-leave was €1182 the first year and
€1283 the second year, €835 and €972 in patients with
AMI, and €1175 and €2803 in patients with AP. No sig-
nificant differences were found between year 1 and year
2 in any of the groups.
Disability pension
On average, 12% of the study participants drew a disability
pension the first year and 11% the second year. There wereTable 5 Annual direct cost per patient of angina pectoris in E
Cos






Hospital care including nursing/caring
staff and premises costs*
0
Staff and treatment□ 1342
Medical service‡ 455
Drugs, materials and medical devices 869
Administrative contacts† 109
Overhead costs and other 314
Total cost 3089
* = Not relevant for primary care and out-patient clinics.
□ = In hospital care, the costs for nursing/caring staff are not included.
‡ =Medical service includes anaesthesia, surgery, postoperative care, intensive care
† = Administrative contacts mainly within primary care and out-patient clinics.no substantial differences between the groups (Table 7).
On average, patients with NCCP, AMI and AP received a
disability pension for 338, 348 and 295 days per year re-
spectively. The mean cost per patient due to productivity
loss because of disability in patients with NCCP was €2345
the first year and €1731 the second year, €2835 and €2710
in patients with AMI, and €2477 and €1713 in patients
with AP. There were no significant differences between
year 1 and year 2 in any of the groups.Total annual societal costs of patients with NCCP, AMI
and AP
The total annual societal cost per patient, including both
direct and indirect costs, is reported in Table 6. The
total cost of patients with NCCP was about €10,068 peruros (€)
t per patient of angina pectoris (n = 49)











ear 2 Year 1 Year 2 Year 1 Year 2
0 2722 1454 2722 1454
1651 1576 545 2918 2196
447 4609 1003 5064 1450
784 890 683 1760 1467
119 4 0 113 120
346 984 400 1297 746
3348 10,785 4084 13,875 7432
, radiology, and laboratory services.
Table 6 Total annual societal cost per patient, in Euros (€)
Non-cardiac chest
pain (n = 99)
Acute myocardial
infarction (n = 51)
Angina
pectoris (n = 49)
Direct cost: Primary care/out-patient clinics Total costs per patient year 1 €3212 €2024 €3089
Total costs per patient year 2 €3616 €3112 €3348
Direct cost: Hospital care Total costs per patient year 1 €3803 €16,387 €10,785
Total costs per patient year 2 €2963 €3103 €4084
Indirect cost Total costs per patient year 1 €3527 €3670 €3652
Total costs per patient year 2 €3014 €3682 €4516
Total annual societal cost per patient €10,068 €15,989 €14,737
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€15,989 and those with AP €14,737.
Cost driving units within primary and hospital care
The most cost driving units within primary care and out-
patient clinics were the physician appointments, which ac-
counted for the main bulk of the staff costs (44%), and the
costs for drugs (28%) (Figure 2). The corresponding cost
driving units within hospital care were hospital care, includ-
ing nursing/caring staff and premises costs (26%), and radi-
ology costs, which is part of the medical service (43%).
Discussion
This study provides a unique and detailed description of
the costs associated with patients with NCCP, AMI and
AP from a societal perspective. This has not previously
been reported. In the present study, we have calculated
the annual societal costs, including direct healthcare
costs and indirect costs, due to productivity loss associ-
ated with NCCP, compared to costs of AMI and AP. Al-
though the majority of patients with NCCP have no
cardiac conditions, many of them believe that they do
and they are often treated in cardiac units. Therefore, it
is of great interest to compare them with cardiac pa-
tients. By comparing them with the more severe cardiac
patients who require more and expensive healthcare re-
sources, we can show the extent of the costs incurred by
those with NCCP, who have a significantly less severe
condition. By highlighting the extent of the costs, we
can also emphasize the importance of early diagnostics
and treatment for these patients which can have a posi-
tive impact on healthcare utilization and costs. This can
also lead to better use of resources for those with cardiac
conditions.
Patients with NCCP incur large costs for the society,
that are similar to or exceed those of AMI and AP, par-
ticularly with regard to primary care costs and indirect
costs due to sick-leave. On average, patients with NCCP
had 54 primary care and out-patient contacts during the
study period, incurring higher costs than patients with
AMI and AP. This is noteworthy since many of these
patients do not have a clear cause and medical diagnosisexplaining the pain. The lack of explanation for the chest
pain can lead to psychological distress, which may ex-
plain these patients’ high number of primary care con-
tacts. According to Eslick [2], there is a relationship
between seeking behavior, symptom severity and higher
level of psychological distress.
All 3 groups had significantly more contacts with pri-
mary care/out-patient clinics and incurred higher costs
in year 2 compared to year 1. This is expected since
most treatment and follow-ups after the index admission
are carried out within primary care and out-patient clinics.
Another reason is that in Sweden, primary care has a strict
gatekeeper role and people are advised to initially consult
primary care for most symptoms [28]. However, when
they experience chest pain, they can seek acute hospital
care without referral from primary care.
Patients with NCCP had fewer admissions and shorter
length of hospital stay, and thereby lower hospital costs,
than those with AMI and AP, which is similar to earlier
research [5,18]. The costs for a hospital admission in the
present study was €2602 for 2.4 days for patients with
NCCP, to be compared with €884 for about 1 day of
hospital admission in a previous study from Sweden
[16], and €3729 for 3.8 days in Ireland [18]. All 3 groups
had significantly fewer admissions, and in AMI and AP
the length of hospital stays were also shorter year 2
compared to year 1, leading to lower costs in all patient
groups. This can partly be explained by the fact that the
index admission was included in the first year. However,
in patients with AMI and AP, the number of admissions
and the length of hospital stay may have decreased after
patients had received their diagnoses and treatment for
these. Although the mean number of admissions and
hospital days was low in all patients, it is recommended
that strategies are implemented in order to reduce the
number of admissions and hospital days since they repre-
sent the greatest part of the cost [16,18]. In this study, one
of the most cost driving units was hospital care, including
nursing/caring staff and premises costs. Coodacre & Cal-
vert [29] recommend short periods of observation with ex-
ercise stress testing rather than overnight admission as a
reasonably cost-effective treatment of patients with NCCP.
Table 7 Productivity loss due to sick-leave and disability pension, in Euros (€)
Productivity Loss
Non-cardiac chest pain (n = 99) Acute myocardial infarction (n = 51) Angina Pectoris (n = 49)
Year 1 Year 2 Year 1 Year 2 Year 1 Year 2
Patients with sick-leave n (%) 16 (16) 11 (11) 10 (20) 8 (16) 13 (27) 11 (22)
Length of sick-leave in days per patient (m ± SD) 86 ± 93 120 ± 123 34 ± 12 73 ± 42 45 ± 33 142 ± 140
Cost of sick-leave in Euros (€) per patient with sick-leave (m ± SD)* 7311 ± 6026 11,549 ± 11,913 4256 ± 2006 6195 ± 4744 4429 ± 2416 12,486 ± 13,261
Total productivity loss cost in Euros (€) due to sick-leave 116,976 127,039 42,560 49,560 57,577 137,346
Cost of sick-leave in Euros (€) per patient in total 1182 1283 835 972 1175 2803
Patients with disability pension due to illness (%) 10 (10) 9 (9) 6 (12) 6 (12) 7 (14) 6 (12)
Length of disability pension in days per patient (m ± SD) 354 ± 35 322 ± 102 365 ± 0 331 ± 83 322 ± 98 268 ± 154
Cost of disability pension in Euros (€) per disabled patient (m ± SD)* 23,220 ± 12,919 19,036 ± 12,116 24,094 ± 7098 23,036 ± 9449 17,342 ± 8291 13,991 ± 11,547
Total productivity loss cost in Euros (€) due to disability pension 232,200 171,324 144,564 138,216 121,394 83,946
Cost of disability pension in Euros (€) per patient in total 2345 1731 2835 2710 2477 1713
Cost of productivity loss in Euros (€) per patient in total 3527 3014 3670 3682 3652 4516
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Figure 2 Cost drivers within primary care and out-patient clinics, and hospital care. 2-year costs in Euros (€).
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http://www.biomedcentral.com/1472-6963/13/403On average, 14%, 18%, and 25% of the patients with
NCCP, AMI and AP were on sick-leave annually with a
mean length of 103, 54 and 94 days respectively. These
percentages were lower than those reported by Eslick &
Talley [7], where 29% of patients with NCCP and 25%
with cardiac chest pain were absent from work due to
chest pain. The participants in the present study had
substantially longer periods of absence from work com-
pared to the 22 days reported by Eslick & Talley. We
also found that about 10% of patients with NCCP re-
ceived a disability pension, which was similar to those
with AMI and AP. However, as reported in a previous
study [15], there were some high users in this cohort
who contributed to high indirect costs.
The annual societal cost of NCCP per patient was
€10,068, which was lower than the costs of patients with
AMI and AP, which were €15,989 and €14,737 respectively.
To obtain a rough indication of the burden of these patient
groups on society, the costs could be extrapolated to alarger context. In 2010, 81,121 patients (2.2% of all pa-
tients) were diagnosed with NCCP, 22,836 with AMI and
27,683 with AP in Sweden [30]. Due to the high prevalence
of NCCP, the cumulative annual national cost of patients
with NCCP would be about €817 million if all patients in-
curred the same costs as in the present study. The corre-
sponding cost for patients with AMI and AP would then
be about €364 million and €408 million respectively.
Strengths and weaknesses
Our results are based on national databases; all healthcare
and social insurance utilization over a 2-year period is
reported. The study has also identified the most cost driv-
ing units in healthcare in connection with patients with
NCCP, AMI and AP. This information is of great interest
when developing new interventions for these patients in
order to support them and reduce societal costs.
All costs associated with the patients’ healthcare uti-
lization and productivity loss were included in the analysis.
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http://www.biomedcentral.com/1472-6963/13/403These also include costs that may have not been related to
NCCP, AMI or AP. It should be acknowledged that this fact
probably causes a slight over-estimation of the costs. How-
ever, including only the costs directly related to the diagno-
ses was not regarded to be feasible, since many symptoms
are indirect consequences of the diagnoses that would then
be excluded. Therefore, including only directly related costs
would mean a marked under-estimation of the costs.
Data regarding sick-leave periods shorter than 15 days
are not registered and are hence not included in the present
analysis. Since short-term sick-leave data are unknown, this
could mean that the indirect costs are under-estimated.
Not including costs related to an individual due to pain
and suffering, or to family members for caring for the in-
dividual, or home care services could mean that the total
societal costs for these patients are under-estimated.
Conclusions and clinical implications
In general, patients with NCCP used significant amount of
healthcare resources and were often absent from work.
The annual societal cost of these patients, €10,068, was
the lowest of the 3 groups. However, due to high preva-
lence of NCCP, the cumulative annual national costs of
these patients could be more than the double of AMI and
AP if all patients incurred the same costs as in this study.
Further research is needed, including development and
evaluation of psycho-educational treatment strategies to
patients with NCCP, targeting management of chest pain
and related symptoms, and thereby reducing healthcare
utilization and costs.
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